CTRI/2021/12/038658尚未招募未知
Comparing outcome of silodosin vs silodosin plus mirabegron for nocturia in patients of BEP/LUTS; a double blinded, randomized controlled trial
Sathaye Shekhar Ulhas0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients presenting to urology OPD with complaints of nocturia with documented BEP at PGIMER, Chandigarh.
- •2.Patients willing to participate in the study.
- •3.Age greater than 40 years
排除标准
- •1.Prostate cancer
- •2.Any contraindication to use mirabegron
- •3.Recurrent UTI
- •4.Patients with H/O AUR or PUC placement or patients who are on PUC.
- •5.Bladder stones.
- •6.Stricture urethra.
- •7.Psychogenic polydipsia
- •8.Prostate surgery in the past.
- •9.Spinal cord trauma, spinal disease affecting bladder function.
- •10.Patient not willing to participate in study.
研究者
相似试验
已完成
4 期
Comparison of the long-term efficacy of silodosin and tamsulodin for the tratment of benign prostatic hyperplasiabenign prostatic hyperplasiaJPRN-UMIN000008538Dokkyo Medical University200
尚未招募
4 期
A study to compare safety and efficacy of silodosin versus mirabegron in patients with lower uretericstoneCTRI/2023/08/057036Dr Rajendera Prasad Government Medical College, Kangra at Tanda, Himachal Pradesh India
尚未招募
不适用
The efficacy combined therapy with silodosin and solifenasin in female overactive bladder patients with voiding symptomKCT0003202Korea University Ansan Hospital338
进行中（未招募）
1 期
A clinical study, which evaluates the effectiveness and the safety of a new medication for prostatic hyperplasia, silodosin, when administered under normal conditions of use in a wide European population.EUCTR2011-000045-20-ESRECORDATI S.p.A
进行中（未招募）
1 期
Effectiveness and safety of silodosin in the treatment of patients with benign prostatic hyperplasia.Benign prostatic hyperplasia.EUCTR2011-000045-20-RORECORDATI S.p.A